Nicola Berlanda

No ORCID on file · 56 papers in corpus · active 1999-2026

Study types

  • review 23
  • article 20
  • other 8
  • book-chapter 2
  • letter 1

Condition tags

  • endometriosis 46
  • mesh:D004715 37
  • adenomyosis 11
  • infertility 10
  • mesh:D017699 8
  • bowel_endometriosis 6
  • dysmenorrhea 4
  • bladder_endometriosis 4
  • dyspareunia 3
  • endometrioma 2
other 2026
Human Reproduction ·doi:10.1093/humrep/deag059

STUDY QUESTION: Are there histological and immunohistochemical patterns of superficial peritoneal endometriotic lesions of symptomatic patients that characterize non-response to dienogest treatment and may suggest progesterone resistance? …

other 2025
Facts, views & vision in ObGyn ·doi:10.52054/FVVO.2025.011225
other 2024
Fertility and sterility ·doi:10.1016/j.fertnstert.2024.01.015
book-chapter 2024
·doi:10.1007/978-3-031-50662-8_1
meta-analysis 2023
Fertility and sterility ·doi:10.1016/j.fertnstert.2023.03.018

We performed a comprehensive narrative synthesis of systematic reviews with meta-analysis published in the last 5 years on the association of endometriosis and adenomyosis with reproductive and obstetric outcomes. This review aimed to defin…

other 2023
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2023.03.017

The evaluation of endometriosis in an adolescent girl is a challenging topic. The initial stage of the disease and the limited diagnostic instrument appropriate for the youth age and for its typical features can reduce the ability of the gy…

review 2023
Human reproduction open ·doi:10.1093/hropen/hoad008

STUDY QUESTION: Is it possible to reduce the cost of GnRH agonist treatment for endometriosis by using non-standard dosing regimens? SUMMARY ANSWER: An extended-interval dosing regimen of a 3.75 mg depot formulation of triptorelin injected …

article 2022
·doi:10.1007/s13669-021-00316-1
review 2022
·doi:10.1007/s13669-022-00336-5
article 2022
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2022.2128644

Purpose The aim of the study was to assess the length of diagnostic delay of symptomatic endometriosis in Italy and analyse the presence of correlations between the socio-demographic status of patients and the clinical characteristics/type …

article 2022
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2022.05.001
other 2022
Archives of gynecology and obstetrics ·doi:10.1007/s00404-021-06243-z

PURPOSE: To evaluate obstetric outcome in women with endometriosis who conceive naturally and receive standard obstetric care in Italy. METHODS: Cases were consecutive women with endometriosis managed in eleven Italian referral centers. Co…

review 2021
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2020.06.004

Endometriosis infiltrating the bowel can be treated medically in accurately selected women not seeking conception and without overt obstructive symptomatology. When the rectosigmoid junction is involved, the probabilities of intestinal symp…

letter 2021
Fertility and sterility ·doi:10.1016/j.fertnstert.2021.06.014
editorial 2019
Expert review of endocrinology & metabolism ·doi:10.1080/17446651.2019.1697675

Adenomyosis is a benign uterine disease defined by the presence of endometrial glands and stroma within the myometrium [1,2]. Although about 35% of affected women may be asymptomatic at the time of...

review 2019
Climacteric : the journal of the International Menopause Society ·doi:10.1080/13697137.2018.1549213

The incidence of endometriosis in middle-aged women is not minimal compared to that in the reproductive age group. The treatment of affected women after childbearing age to the natural transition toward menopause has received considerably p…

article 2019
European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2019.100073

OBJECTIVE: Ovarian hyper-stimulation during IVF is associated with a significant raise in serum estrogens and one may expect detrimental effects on estrogen-dependent diseases such as endometriosis. However, available evidence from large ca…

article 2019
Human reproduction open ·doi:10.1093/hropen/hoz009

A network of endometriosis experts from 16 Italian academic departments and teaching hospitals distributed all over the country made a critical appraisal of the available evidence and definition of 10 suggestions regarding measures to be de…

article 2018
Human Reproduction ·doi:10.1093/humrep/dey368

Elagolix, an orally active non-peptidic GnRH antagonist, has been approved by the Food and Drug Administration for the management of moderate to severe pain associated with endometriosis. As the degree of ovarian suppression obtained with e…

article 2017
·doi:10.1089/gyn.2017.0021

Background: The most frequent congenital anomalies of the genital tract in women are caused by irregular development of the Müllerian ducts. At present, known Müllerian anomalies include abnormal ductal unification, aplasia, and vaginal cys…

review 2017
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC ·doi:10.1016/j.jogc.2017.07.011
review 2017
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2017.05.010
review 2017
Archives of gynecology and obstetrics ·doi:10.1007/s00404-017-4448-z
review 2017
International journal of women's health ·doi:10.2147/ijwh.s119724

Endometriosis has a multifactorial etiology. The onset and progression of the disease are believed to be related to different pathogenic mechanisms. Among them, the environment and lifestyle may play significant roles. Diet, dietary supplem…

review 2017
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719117707054